Trials / Recruiting
RecruitingNCT07224243
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54,000 (estimated)
- Sponsor
- Frederic T Billings IV · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter, cluster-randomized, cluster-crossover clinical trial evaluates the impact of three intraoperative FiO2 (Fraction of Inspired Oxygen) oxygenation strategies-lower (FiO₂ 0.21-0.40), intermediate (FiO₂ 0.40-0.80), and higher (FiO₂ 0.80-1.00)-on postoperative organ injury and mortality in adult surgical patients. The trial aims to determine the optimal oxygenation strategy to improve perioperative outcomes.
Detailed description
The Intraop Ox trial will enroll adult patients undergoing surgery with tracheal intubation. Participating hospitals will be randomly assigned (as a unit) to administer one of three oxygenation strategies during maintenance anesthesia (lower FiO₂ \[0.21-0.40\], intermediate FiO₂ \[0.40-0.80\], or higher \[FiO₂ 0.80-1.00\] each period (month). The primary outcome is a composite of organ injury (acute kidney injury, myocardial injury, lung injury, stroke) or death within 30 days. Secondary outcome is 30-day mortality. Exploratory outcomes are individual components of the composite primary endpoint, surgical site infection, length of stay, and hypoxemia. The study is conducted under a waiver of informed consent due to minimal incremental risk of participating and impracticability of obtaining consent in this cluster-randomized design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Lower FiO2 | FiO₂ 0.21-0.40 or lowest FiO₂ to maintain SpO₂ ≥ 94% during maintenance anesthesia |
| OTHER | Intermediate FiO2 | FiO₂ 0.40-0.80 or lowest FiO₂ to maintain SpO₂ ≥ 94% during maintenance anesthesia |
| OTHER | Higher FiO2 | FiO₂ \> 0.80 to maintain SpO₂ ≥ 94% during maintenance anesthesia |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2028-02-01
- Completion
- 2028-04-01
- First posted
- 2025-11-04
- Last updated
- 2026-04-07
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT07224243. Inclusion in this directory is not an endorsement.